Skip to main content
Equibles

Andy Shea

Analyst

William Blair

Equibles does not estimate personal net worth.

About Andy Shea

Andy Shea is recorded as Analyst at William Blair. Andy Shea has spoken on 8 earnings calls and 2 other investor events across 7 companies, most recently for Exelixis, Inc. on August 5, 2026. Those appearances were for Atea Pharmaceuticals, Inc. (AVIR), Altimmune, Inc. (ALT), Exelixis, Inc. (EXEL), Lantheus Holdings, Inc. (LNTH), Telix Pharmaceuticals Ltd (TLX) and 2 other companies. The companies whose calls Andy Shea spoke on are classified in the Healthcare sector.

Andy Shea on recent calls

“I'm a research analyst here at William Blair. I cover Lantheus. I'm required to inform you that for a complete list of research disclosures and potential conflicts of interest, please visit our website at williamblair.com. So we're pleased to have John Wiggins, the VP, head of asset leadership, with us today.”
Analyst — William Blair, William Blair 46th Annual Growth Stock Conference ·
“I'm the research analyst here at William Blair, who covers Tealix.”
Analyst — William Blair, William Blair 46th Annual Growth Stock Conference ·
“Just a question on the CDA data presentation. The other GLP-1 group of gone assets, so those of you guys will have both the VC data set and also the NAPL data set.”
Analyst — William Blair, Altimmune, Inc. Q1 FY2026 Earnings Call ·

Affiliation history

  • William Blair

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity